BioNTech SE (BNTX) Change in Interest Receivables (2018 - 2019)
BioNTech SE (BNTX) reported Change in Interest Receivables of -$5.1 million for Q4 2019, down 134.39% on a YoY basis from $14.7 million in Q4 2018, and down 134.39% sequentially from $14.7 million in Q4 2018.
BioNTech SE (BNTX) Change in Interest Receivables (2018 - 2019) Analysis & Trends
BioNTech SE (BNTX) has 2 years of Change in Interest Receivables data on file, last reported at -$5.1 million in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Interest Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -266,893.98 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | BioNTech SE | 21.56 Bn | 21.56 Bn | 668.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -5.06 Mn |
| Dec 31, 2018 | 14.72 Mn |